NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 03 04:00PM ET
0.9639
Dollar change
-0.0041
Percentage change
-0.42
%
Index- P/E- EPS (ttm)-1.00 Insider Own2.19% Shs Outstand40.00M Perf Week-5.50%
Market Cap38.56M Forward P/E- EPS next Y-0.07 Insider Trans0.00% Shs Float39.13M Perf Month0.41%
Enterprise Value57.96M PEG- EPS next Q-0.11 Inst Own1.93% Short Float2.98% Perf Quarter-20.99%
Income-22.56M P/S- EPS this Y57.87% Inst Trans-4.25% Short Ratio2.21 Perf Half Y-46.45%
Sales0.00M P/B- EPS next Y82.67% ROA-85.79% Short Interest1.17M Perf YTD-45.54%
Book/sh-0.07 P/C3.05 EPS next 5Y55.20% ROE- 52W High3.02 -68.08% Perf Year-15.82%
Cash/sh0.32 P/FCF- EPS past 3/5Y46.92% 29.27% ROIC-76.89% 52W Low0.81 19.29% Perf 3Y-68.96%
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility3.32% 4.54% Perf 5Y-95.79%
Dividend TTM- EV/Sales- EPS Y/Y TTM62.29% Oper. Margin- ATR (14)0.05 Perf 10Y-
Dividend Ex-Date- Quick Ratio3.58 Sales Y/Y TTM- Profit Margin- RSI (14)44.42 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio3.72 EPS Q/Q68.79% SMA20-2.95% Beta2.87 Target Price7.00
Payout- Debt/Eq- Sales Q/Q- SMA50-5.14% Rel Volume0.93 Prev Close0.97
Employees9 LT Debt/Eq- EarningsMay 13 BMO SMA200-28.25% Avg Volume527.44K Price0.96
IPOMay 25, 2018 Option/ShortNo / Yes EPS/Sales Surpr.28.57% - Trades Volume491,861 Change-0.42%
Date Action Analyst Rating Change Price Target Change
May-28-21Upgrade Gabelli & Co Sell → Hold
Mar-15-21Upgrade H.C. Wainwright Neutral → Buy $2.50
Jun-02-20Downgrade RBC Capital Mkts Outperform → Sector Perform $7 → $2
Jan-21-20Downgrade Gabelli & Co Buy → Sell
Dec-11-19Downgrade SVB Leerink Outperform → Mkt Perform
Jun-21-19Initiated H.C. Wainwright Buy $17
Jul-02-25 04:30PM
Jun-30-25 07:00AM
Jun-25-25 07:00AM
Jun-11-25 07:00AM
May-19-25 07:00AM
03:08AM Loading…
May-14-25 03:08AM
02:52AM
May-13-25 07:00AM
May-06-25 07:00AM
Apr-30-25 04:30PM
Apr-29-25 08:00AM
Apr-14-25 08:00AM
Feb-08-25 02:06AM
12:16AM
Feb-07-25 07:00AM
08:00AM Loading…
Jan-31-25 08:00AM
Nov-21-24 08:30AM
Nov-15-24 02:10AM
Nov-14-24 07:00AM
Nov-11-24 08:00AM
Oct-28-24 10:19AM
07:49AM
05:00AM
Oct-25-24 11:03AM
Oct-10-24 08:30AM
Oct-09-24 05:00PM
Sep-24-24 10:33AM
Sep-10-24 07:00AM
Sep-06-24 04:30PM
Aug-17-24 08:09AM
07:00AM Loading…
Aug-14-24 07:00AM
Aug-10-24 08:18AM
Aug-07-24 04:30PM
Aug-06-24 05:30PM
Aug-02-24 08:00AM
Jul-22-24 07:30AM
Jun-21-24 08:00AM
Jun-05-24 08:00AM
May-31-24 08:00AM
May-14-24 08:21AM
May-13-24 10:49PM
11:53AM
07:00AM
May-06-24 08:00AM
Apr-29-24 08:00AM
Apr-02-24 10:22AM
Mar-29-24 12:09AM
Mar-28-24 11:53AM
07:00AM
Mar-21-24 04:30PM
Mar-15-24 08:00AM
Mar-07-24 07:57AM
Mar-06-24 08:00AM
Feb-01-24 03:03PM
Jan-30-24 07:00AM
Dec-04-23 08:00AM
Nov-15-23 12:22PM
12:08AM
Nov-14-23 07:00AM
Nov-07-23 08:30AM
Oct-24-23 08:00AM
Oct-12-23 09:15AM
Aug-11-23 10:10PM
07:00AM
Aug-04-23 05:00PM
Jun-27-23 09:50AM
Jun-21-23 08:35AM
Jun-12-23 06:23PM
May-12-23 07:00AM
May-10-23 09:16AM
Apr-20-23 05:00PM
Apr-13-23 12:00PM
Mar-18-23 02:06AM
Mar-16-23 09:16PM
07:00AM
Mar-09-23 05:00PM
Jan-11-23 06:00PM
Dec-15-22 08:00AM
Nov-10-22 07:00AM
Nov-03-22 08:00AM
Oct-20-22 07:30AM
Oct-17-22 05:19PM
Sep-19-22 07:30AM
Sep-07-22 09:15AM
Sep-01-22 04:15PM
Aug-17-22 09:45AM
Aug-16-22 09:00PM
Aug-12-22 07:00AM
Jul-11-22 02:31PM
07:30AM
Jul-06-22 04:30PM
Jun-14-22 05:00PM
May-13-22 07:00AM
May-11-22 08:00AM
Apr-25-22 05:06PM
Mar-28-22 10:19AM
07:00AM
Mar-21-22 08:00AM
Mar-10-22 08:00AM
Feb-08-22 05:00PM
Iterum Therapeutics Plc operates as a pharmaceutical company, which engages in the development and commercialization of sulopenem. The company was founded by Corey N. Fishman on June 24, 2015 and is headquartered in Dublin, Ireland.